PLC

NASDAQ

Principal U.S. Large-Cap Multi-Factor Core Index ETF

Sectorn/aIndustryn/aIPOn/a

News3/Ratings1

The investment seeks to provide investment results that closely correspond, before expenses, to the performance of the Nasdaq US Large Cap Select Leaders Core Index. Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of U.S. companies with large market capitalizations that compose the index at the time of purchase. The index uses a quantitative model designed to identify equity securities of companies in the Nasdaq US Large Cap Index that exhibit potential for high degrees of value, quality growth and strong momentum.

Latest news

3 items

766dNEWS
AstraZeneca Says Lynparza/Imfinzi Combo Shows Strong Clinical Benefit Vs. Chemotherapy In Endometrial Cancer
Monday, AstraZeneca Plc (NASDAQ:PLC) released latest analysis of the results from the DUO-E Phase 3 trial of Imfinzi (durvalumab) plus platinum-based chemotherapy followed by Imfinzi plus Lynparza (olaparib) (Lynparza and Imfinzi arm) in mismatch repair proficient (pMMR) advanced or recurrent endometrial cancer compared to chemotherapy alone. The data demonstrated an improvement in multiple key secondary efficacy endpoints, particularly in patients with mismatch repair proficient (pMMR) advanced or recurrent endometrial cancer compared to chemotherapy alone. A post-hoc exploratory subgroup analysis assessed patients by mismatch repair (MMR) status, a biomarker of interest in endometria
1682dANALYST
RBC Capital reiterated coverage on Park Lawn with a new price target
RBC Capital reiterated coverage of Park Lawn with a rating of Outperform and set a new price target of $50.00 from $46.00 previously
1802dANALYST
RBC Capital reiterated coverage on Park Lawn with a new price target
RBC Capital reiterated coverage of Park Lawn with a rating of Outperform and set a new price target of $43.00 from $39.00 previously